Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Zidi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Die Pharmazie|May 27, 2011
Golimumab and immunogenicity? 2010 and beyondI Zidi, A Bouaziz, N Ben Amor
Die Pharmazie|March 12, 2011
Dermatologic adverse events: golimumab, friend or foe?I Zidi, A Bartegi, Amor N Ben
Journal of Physiology and Biochemistry|April 21, 2010
Soluble HLA-G induces NF-kappaB activation in natural killer cellsI Zidi, C Guillard, E D Carosella, et al.
The West Indian Medical Journal|September 12, 2013
Nephropathy following type 2 diabetes mellitus in Tunisian populationA Bouaziz, I Zidi, N Zidi, et al.
Scandinavian Journal of Immunology|July 13, 2010
Golimumab therapy of rheumatoid arthritis: an overviewI Zidi, A Bouaziz, W Mnif, et al.
Cellular and Molecular Life Sciences : CMLS|October 31, 2006
Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducersI Zidi, C Guillard, C Marcou, et al.
Journal of Viral Hepatitis|January 27, 2015
Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitisA B Laaribi, I Zidi, N Hannachi, et al.
HLA|March 10, 2016
HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patientsI Zidi, A B Laaribi, D Bortolotti, et al.
Journal of Viral Hepatitis|April 22, 2017
Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infectionA B Laaribi, D Bortolotti, N Hannachi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Die Pharmazie|May 27, 2011
Golimumab and immunogenicity? 2010 and beyondI Zidi, A Bouaziz, N Ben Amor
Die Pharmazie|March 12, 2011
Dermatologic adverse events: golimumab, friend or foe?I Zidi, A Bartegi, Amor N Ben
Journal of Physiology and Biochemistry|April 21, 2010
Soluble HLA-G induces NF-kappaB activation in natural killer cellsI Zidi, C Guillard, E D Carosella, et al.
The West Indian Medical Journal|September 12, 2013
Nephropathy following type 2 diabetes mellitus in Tunisian populationA Bouaziz, I Zidi, N Zidi, et al.
Scandinavian Journal of Immunology|July 13, 2010
Golimumab therapy of rheumatoid arthritis: an overviewI Zidi, A Bouaziz, W Mnif, et al.
Cellular and Molecular Life Sciences : CMLS|October 31, 2006
Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducersI Zidi, C Guillard, C Marcou, et al.
Journal of Viral Hepatitis|January 27, 2015
Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitisA B Laaribi, I Zidi, N Hannachi, et al.
HLA|March 10, 2016
HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patientsI Zidi, A B Laaribi, D Bortolotti, et al.
Journal of Viral Hepatitis|April 22, 2017
Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infectionA B Laaribi, D Bortolotti, N Hannachi, et al.
Pageof 1